Answers are grounded in this paper and cite their sources.
Dual-AAV delivery of oversized editors couples vector manufacturing, product quality, co-delivery and gene correction, yet process models rarely carry this coupling or state what their data can identify. We built a modular computational digital twin spanning manufacturing, dual-vector reconstitution and gene-specific correction. An independent reconstruction of a published 21-state production model agreed across three stiff solvers (< 0.14%) but retained a 21.8% mean absolute gap to source observations at 46 h; its 14-parameter space was rank-deficient (12/14; condition number 6.4×10²¹), improving to 6.0×10³ after reduction. Fourteen scenario studies traced product quality to function: within the assumed surrogate equations and input distributions, variance-based sensitivity assigned 52% of functional variance to the A:B ratio (correlation screen: 2%), and titre-only release classified function at chance (AUC 0.49) versus 0.98 for a functional assay. All analyses are computational; no experimental validation is claimed.
No takes yet. Share an insight, caveat, or question.
Faizan Ahmad (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: